IVBXF
Price
$4.80
Change
-$0.06 (-1.23%)
Updated
Dec 16 closing price
MBXBF
Price
$0.25
Change
+$0.01 (+4.17%)
Updated
Dec 17 closing price
Ad is loading...

IVBXF vs MBXBF

Header iconIVBXF vs MBXBF Comparison
Open Charts IVBXF vs MBXBFBanner chart's image
Innovent Biologics
Price$4.80
Change-$0.06 (-1.23%)
Volume$1K
CapitalizationN/A
Microbix Biosystems
Price$0.25
Change+$0.01 (+4.17%)
Volume$9K
CapitalizationN/A
IVBXF vs MBXBF Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVBXF vs. MBXBF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Hold and MBXBF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (IVBXF: $4.80 vs. MBXBF: $0.25)
Brand notoriety: IVBXF and MBXBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 43% vs. MBXBF: 64%
Market capitalization -- IVBXF: $7.65B vs. MBXBF: $33.84M
IVBXF [@Biotechnology] is valued at $7.65B. MBXBF’s [@Biotechnology] market capitalization is $33.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileMBXBF’s FA Score has 0 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • MBXBF’s FA Score: 0 green, 5 red.
According to our system of comparison, both IVBXF and MBXBF are a bad buy in the long-term.

Price Growth

IVBXF (@Biotechnology) experienced а -1.13% price change this week, while MBXBF (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IVBXF($7.65B) has a higher market cap than MBXBF($33.8M). IVBXF YTD gains are higher at: -2.439 vs. MBXBF (-11.165).
IVBXFMBXBFIVBXF / MBXBF
Capitalization7.65B33.8M22,630%
EBITDAN/AN/A-
Gain YTD-2.439-11.16522%
P/E RatioN/A9.72-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MBXBF: Fundamental Ratings
MBXBF
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
58
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
N/A
WXXWY - IVBXF
24%
Poorly correlated
-0.99%
BNTC - IVBXF
23%
Poorly correlated
+1.51%
MBXBF - IVBXF
7%
Poorly correlated
+2.49%
IUGNF - IVBXF
5%
Poorly correlated
N/A
ISCO - IVBXF
5%
Poorly correlated
N/A
More

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CMND have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
+2.49%
CMND - MBXBF
25%
Poorly correlated
-3.05%
BVNRY - MBXBF
20%
Poorly correlated
-0.15%
MMIRF - MBXBF
15%
Poorly correlated
N/A
IVEVF - MBXBF
8%
Poorly correlated
N/A
IVBXF - MBXBF
7%
Poorly correlated
N/A
More